Research Article Metronidazole neuropathy. Br Med J 1977; 2 doi: https://doi.org/10.1136/bmj.2.6087.610 (Published 03 September 1977) Cite this as: Br Med J 1977;2:610 Article Related content Metrics Responses Peer review Related articles No related articles found. See more GSK settles most US lawsuits over Zantac for $2.2bn BMJ October 11, 2024, 387 q2249; DOI: https://doi.org/10.1136/bmj.q2249 What do we know about covid-19’s effects on the gut? BMJ May 01, 2024, 385 q842; DOI: https://doi.org/10.1136/bmj.q842 Cholera: Malawi is in grip of its deadliest outbreak BMJ February 09, 2023, 380 p328; DOI: https://doi.org/10.1136/bmj.p328 Emergency care is in “dire” situation after loss of NHS beds, says royal college BMJ May 31, 2022, 377 o1376; DOI: https://doi.org/10.1136/bmj.o1376 GP efforts to cut antibiotic use failed to curb spread of drug resistant E coli, evaluation finds BMJ August 05, 2021, 374 n1953; DOI: https://doi.org/10.1136/bmj.n1953 Cited by... Metronidazole-induced encephalopathy: Symmetrical hyperintensity on imagingFulltext PDF Metronidazole-induced cerebellar syndromeFulltext PDF Metronidazole-induced reversible cerebellar dysfunctionFulltext PDF Abstract Reversible optic neuropathy secondary to metronidazoleFulltext PDF Abstract Metronidazole-induced encephalopathy after prolonged metronidazole course for treatment of C. difficile colitisFulltext PDF Abstract Efficacy and Safety of Metronidazole for Pulmonary Multidrug-Resistant TuberculosisFulltext PDF Abstract Walking unsteadily: a case of acute cerebellar ataxiaFulltext PDF Abstract
